Niyondiko, N. (2024) Clinical Management of Diabetic Ketoacidosis in Pregnancy: A Review of Current Literature. Open Access Library Journal, 11, 1-25. doi: 10.4236/oalib.1112246 .

Difficulty sleeping can also affect your insulin. But there are things you can do to manage blood sugar at night and improve your sleep. Managing diabetes — whether you have type 1 or type 2 ...

Out of all the types of coffee-brewing devices, from espresso machines to Keurigs, it is the humble drip-style coffee maker that remains the most popular choice among Americans. To determine the ...

Stopping cancer cells from accessing fat can improve certain types of cancer treatment, a new study has revealed. Latest research from Van Andel Institute in Michigan has suggested that cutting off ...

To manage blood sugar levels and prevent hyperglycemia, individuals should follow their doctor’s recommendations, which may include taking insulin, eating a nutritious diet, exercising regularly, and ...

Michelle Yeoh Admits She Felt Like A ‘Failure’ During Fertility Struggles; Says ‘You Have To Let Go’ Georgie & Mandy’s First Marriage Showrunner Reveals The Reason Behind Not Involving ...

But on Halloween afternoon, Lexicon was haunted again as an FDA advisory committee voted 11-3 that the benefits of Zynquista do not outweigh the risks when the treatment is used as an accompanying ...

It’s a lifelong condition that requires treatment ... there is no insulin available. This results in rapid deterioration and requires immediate emergency medical attention. A DKA diagnosis ...

there continued to be uncertainties regarding the risk of DKA in the revised target population. Additionally, data were limited for patients with eGFR <60, therefore definitive conclusions on the ...

Researchers at the Terasaki Institute for Biomedical Innovation (TIBI) have developed a revolutionary injectable granular filler that could transform the way diabetic wounds are treated ...

with the US Food and Drug Administration for a subcutaneous formulation of Leqembi (lecanemab), seeking approval for the beta-amyloid-targeting Alzheimer's disease drug as a maintenance treatment.